ABC News on NAION incidence rates among GLP-1 users and comparator groups reported by the FDA.

KLEORYClaim and record

ABC News

As posted by @ABC on X

Compared on: the record on NAION incidence rates among GLP-1 users and comparator groups reported by the FDA..

THE CLAIM · NOV 15, 2026

“The FDA found 6.4 cases per 100,000 person-years among GLP-1 users, compared with 3.8 among those receiving a placebo or another diabetes medication”

ABC News, as posted by @ABC · Read the post

THE RECORD

“showed an occurrence of 6.4 NAION cases per 100,000 person-years (PY) in patients treated with GLP-1 RAs compared to 3.8 NAION cases per 100,000 PY for patients treated with a placebo or a non-GLP-1 RA glucose-lowering medication.”

FDA Requires Safety Labeling Changes for GLP-1 RAs · Read

OPEN

Also in this post